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DABCO catalystAbstract A selective method for the synthesis of annulated pyrano[2,3-d]pyrimidines has been
developed. It was shown that base catalysis is more efﬁcient in this reaction, rather than acid
catalysis as it is believed that 1,4-diazabicyclo[2.2.2]octane (DABCO) is N-type base catalyst used
for the synthesis of pyrano[2,3-d]pyramidine derivatives via one-pot three component condensation
reactions of various aromatic aldehydes, active methylene compounds and barbituric acid in
aqueous ethanol carried at normal temperature. The potential application of DABCO in organic
synthesis increasing rapidly because of its reaction simplicity, less pollution, and minimum reaction
time, high yields of the biological active products, uses less toxic solvents and low cost chemicals.
ª 2014 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Multicomponent reactions (MCRs) have enormous beneﬁt
with their high yields of products, ease of execution in the
aim of analysis of combinatorial chemistry [32]. However, in
the past decade there has been tremendous development in
three- and four-component reactions and great efforts were
taken to develop new MCRs [29,7]. Solid-phase organic syn-
thesis is a background of generating libraries of moleculesfor the discovery of biologically active leads and also for the
optimization of potent drug molecules. Many organic solvents
are harmful and their use should therefore be minimized as far
as possible. Green alternatives under investigation for organic
reactions are water [8,11], supercritical ﬂuids, in particular
CO2 [19] and solvent-free condition (SFC) [23]. The use of
water as the reaction medium exhibits a signiﬁcant advantage
because this green solvent is highly polar and therefore
immiscible with most organic compounds [21]. Moreover the
water-soluble catalyst resides and operates in the aqueous
media, and separation of organic compounds is thus easy.
Reactions in aqueous media are generally environmentally
safe, devoid of any carcinogenic effects, simple work up,
comparatively cheaper to operate and particularly important
in industry. Thus, there is a need for developing multicompo-
nent reactions (MCR’s) in aqueous ethanol and without the
use of harmful organic solvent.
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considerable interest in heterocyclic chemistry as the fusion
of biodynamic heterosystems has proved to be very attractive
and constructive for the design of a new molecular framework
of potential drugs with varying pharmacological activities. A
major challenge of the modern synthetic chemistry is to design
highly efﬁcient chemical reaction sequences which provide
molecules containing maximum complexity and structural
diversity with interesting bioactivities in minimum number of
synthetic steps. Recently, organocatalyst has increased extre-
mely in the last few years as a result of both the novelty of
the concept and, more importantly, the fact that the efﬁciency
and the selectivity of many organocatalyst reactions meet the
standards of established organic reactions. One of these org-
ano catalysts is the 1,4-diazabicyclo[2.2.2]octane (DABCO)
which has received considerable attention as an inexpensive,
eco-friendly, high reactive and non-toxic base catalyst for var-
ious organic synthesis, affording the corresponding products in
excellent yields with high selectivity. Pyrano[2,3-d]pyrimidine is
unsaturated six membered heterocycle which is formed by
fusion of pyran and pyrimidine rings together, consisting of
one oxygen atom at position number 8 and two nitrogen atoms
at position number 1 and 3 respectively. If pyrano[2,3-d]pyrim-
idine moieties are clubbed into one molecule, then resultant
derivative enhances its pharmaceutical activity as abundant in
biologically active compounds such as antitumour [2], cardio-
tonic [12], antibronchitic [17] and antifungal activity [26]. Some
of them exhibit antihypertensive activity [6], antimalarial [9],
analgesic [20,30]; and antiviral evaluation [27] properties. Pyr-
ano[2,3-d]pyrimidines are building blocks used to evaluate their
antimicrobial activities and various derived natural products
are also used as a drug for insomnia treatment [24]. Therefore,
for the preparation of these complex molecules large efforts
have been directed toward the synthetic manipulation of pyr-
ano[2,3-d]pyrimidine derivatives. As a result, a number of
reports have appeared in the literature which usually requires
forcing conditions, long reaction times and complex synthetic
pathways. Pyrano[2,3-d]pyrimidine synthesis was reported
under various conditions such as microwave irradiation
[10,13], ultrasonic irradiation [18], solvent free condition and
in aqueous medium in the absence of catalysts [14]); sulfonic
acid nanoporous silica (SBA-Pr-SO3H) [34], diammonium
hydrogen phosphate (DAHP) [3], L-proline (Heravi et al.,
2010); [5], H14 [NaP5W30O110] (Heravi et al., 2010), ionic liquids
[33]. Reported methods appearing in the literature usually
require forcing conditions, long reaction time, create wastes,
need complex synthetic pathway and involved organic solvents
as well high energy to proceed. So, due to environmental con-
cerns associated with aspects of organic solvents, development
of aqueous phase synthesis of pyrano[2,3-d]pyrimidines is of
considerable interest in this research to cater short reactionAr H
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Scheme 1 General synthesis of substtime, environmentally friendly procedure and excellent yields
by this proposed route. Aqueous ethanol (ethanol:water) in
place of organic solvents was used besides being non-hazard-
ous, it is cheap, readily available and simple to handle so, we
describe here a rapid, energy efﬁcient, green and economically
viable and easy (room temperature) protocol for the synthesis
of pyrano[2,3-d]pyrimidine derivatives by using DABCO cata-
lyst (Scheme 1).
2. Materials and methods
All chemicals were obtained from Aldrich Chemical Co. and
S.D. Finechem Co. and used without further puriﬁcation.
Melting points were determined by open capillary method
and were uncorrected. 1H NMR spectra were obtained on a
BRUKER instrument (300 MHz). IR spectra were recorded
on a Perkin–Elmer 298 spectrophotometer using KBr pellet
and 13C NMR (100 MHz) spectra were recorded in DMSO-
d6 as solvent with TMS as internal standard. Chemical shifts
are reported in ppm and mass spectra were measured using
high resolution GC–MS (DFS) thermo spectrometers with
EI (70 EV). Reactions have been monitored by thin layer chro-
matography on 0.2-mm precoated plates of silica gel G60 F254
(Merck). Visualization was made with UV light (254 and
365 nm) or with an iodine vapor Scheme 2).
2.1. General procedure for the preparation of pyrano[2,3-
d]pyrimidinones
Aromatic aldehydes (1), active methylene compound (2), bar-
bituric acid (3) (2 mmol each) and 10 mol% 1,4-diazabicy-
clo[2,2,2]octane (DABCO) were taken in an RB ﬂask with
15 ml solvent ethanol:water (1:1 ratio) mixture and stirred
for 30–40 min at room temperature. The reaction was moni-
tored by thin layer chromatography using eluent petroleum
ether and ethyl acetate 7:3. The solid compound was ﬁltered,
washed with cold water and recrystallization from ethanol to
obtain pure product pyrano[2,3-d]pyrimidine derivatives.
2.2. Spectral data for synthesized pyrano[2,3-d]pyrimidine
products
2.2.1. Ethyl7-amino-5-(4-methylphenyl)-2,4-dioxo-1,3,4,5-
tetrahydro-2H-pyrano[2,3-d]pyrimidine-6-carboxylate (4a)
IR (KBr, cm1): 3395, 3103, 2223, 1912, 1845, 1662, 1567,
1734, 1H NMR (300 MHz, DMSO): d 2.36 (s, 3H, CH3), 2.6
(s, 3H, CH3), 4.13 (s, 1H, H-5), 5.21 (s, 2H, CH2), 7.12 (m,
2H, H-Ar), 7.20 (m, 2H, H-Ar), 7.60 (br s, 2H, NH2), 10.89
(s, 1H, NH), 11.43 (s, 1H, NH) ppm, 13C NMR (100 MHz,
DMSO-d6, d, ppm) d: 20.9, 88.7, 98.3, 115.5, 127.5, 128.1,N
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Scheme 2 Possible mechanism of pyrano[2,3-d]pyrimidine products.
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m/z, 293, 292, 249, 77, 57, 43.
2.2.2. Ethyl 7-amino-2,4-dioxo-5-phenyl-1,3,4,5-tetrahydro-2H-
pyrano[2,3-d]pyrimidine-6-carboxylate (4b)
IR (KBr, mcm1): 3381, 3168, 2289, 2202, 1664, 1708, 1560; 1H
NMR (300 MHz, DMSO-d6, d, ppm): 3.6 (s, 3H, CH3), 4.19 (s,
1H, H-5), 4.31 (s, 2H, CH2), 6.07 (s, 1H, H-Ar), 7.10 (s, br, 2H,
NH2), 6.51–8.13 (m, 5H-Ar), 11.12 (br, s, 1H, NH), 12.14 (br,
s, 1H, NH) PPm; 13C NMR (100 MHz, DMSO-d6, d, ppm) d:
30.02, 60.2, 69.2, 128.6, 129.8, 135.4, 156.3, 152.8, ppm. EI-
MS: (m/z) = 281 (M+), 256, 236, 205, 173, 141.
2.2.3. Ethyl 7-amino-5-(4-methoxyphenyl)-2,4-dioxo-1,3,4,5-
tetrahydro-2H-pyrano[2,3-d]pyrimidine-6-carboxylate (4c)
IR (KBr, m cm1): 3413, 3278, 2239, 2165, 1878, 1662, 1543; 1H
NMR (300 MHz, DMSO-d6, d, ppm): 3.32 (s, 3H, OCH3), 4.41
(1H, s, H-5), 3.71 (s, 2H, CH2), 2.49 (s, 3H, CH3) 6.93 (m, 2H,
H-Ar), 7.65 (m, 2H, H-Ar), 9.07 (2H, br, s, NH2), 11.09-10.03
(s, br, 2H, NH); 13C NMR (100 MHz, DMSO-d6, d, ppm) d:
33.03, 37.2, 55.8, 75.6, 114.2, 130.1, 134.i, 143.9, 150.5,
157.2, 162.4, 167.3 ppm. EI-MS: (m/z) = 89 (M+), 269, 232,
221, 201, 176, 149, 110.
2.2.4. Ethyl7-amino-5-(3,4-dimethoxyphenyl)-2,4-dioxo-1,3,4,
5-tetrahydro-2H-pyrano[2,3-d]pyrimidine-6- carboxylate (4d)
IR (KBr, m cm1): 3495, 3303, 3123, 2987, 2164, 1662, 1576; 1H
NMR (300 MHz, DMSO-d6, d, ppm) d: 3.12 (s, 3H, CH3), 3.5
(s, 2H, CH2), 3.6–4.02 (s, 3H, OCH3), 4.2 (s, 1H, H-5), 7.1 (s,
2H, NH2), 11.1 (s, 1H, NH), 11.4 (s, 1H, NH), 8.27 (m, 2H,
H-Ar), 8.47 (m, 2H, H-Ar); 13C NMR (100 MHz, DMSO-d6,
d, ppm) d: 37.9, 56.3, 57.4, 79.7, 114.2, 135.8, 146.9, 149.4,
150.1, 163.8 ppm. EI-MS: (m/z) = 342 (M+), 312, 295, 279,
249, 243, 220, 217, 149.2.2.5. Ethyl 7-amino-5-(3-hydroxyphenyl)-2,4-dioxo-1,3,4,5-
tetrahydro-2H-pyrano[2,3-d]pyrimidine-6- carboxylate (4e)
IR (KBr, m cm1):3439, 3337, 3193, 3028, 2206, 1677, 1625; 1H
NMR (300 MHz, DMSO-d6, d, ppm) 3.6 (s, 3H, CH3), 3.91 (s,
2H, CH2), 4.10 (s, 1H, H-5), 6.56 (br s, 2H, NH2), 6.59 (m, 1H,
H-Ar), 7.04–7.10 (m, 3H, H-Ar), 9.33 (br s, 1H, OH), 11.09 (br
s, 1H, NH), 12.07 (br s, 1H, NH) ppm; 13C NMR (100 MHz,
DMSO-d6, d, ppm) d: 35.6, 59.9, 89.5, 114.7, 114.9, 118.8,
120.1,130.1, 146.5, 150.4, 153.1, 158.1, 158.5, 163.3 ppm; MS:
m/z (%) = 298 (M+), 249, 232, 188,142, 128, 115.
2.2.6. Ethyl7-amino-5-(4-hydroxyphenyl)-2,4-dioxo-1,3,4,5-
tetrahydro-2H-pyrano[2,3-d]pyrimidine-6-carboxylate (4f)
IR (KBr, m cm1): 3343, 3191, 3142, 2209, 1909, 1796, 1685;
1H NMR (300 MHz, DMSO-d6, d, ppm): 3.69 (s, 1H, H-5),
3.17 (s, 2H, CH2), 2.43 (s, 3H, CH3), 7.31 (br s, 2H, NH2),
5.97 (m, 2H, H-Ar), 6.74 (m, 2H, H-Ar), 6.07 (br s, 1H,
OH), 10.47 (br s, 1H, NH), 11.03 (br s, 1H, NH) ppm: 13C
NMR (100 MHz, DMSO-d6, d, ppm) d: 29.03, 37.2, 61.5,
75.2, 79.9, 115.3, 134.4, 142.3, 150.4, 155.5, 160.1,
163.5 ppm. EI-MS: (m/z) = 298 (M+), 249, 232, 188, 142,
128, 115.
2.2.7. Ethyl7-amino-5-(4-chlorophenyl)-2,4-dioxo-1,3,4,5-
tetrahydro-2H-pyrano[2,3-d]pyrimidine-6-carboxylate (4g)
IR (KBr, cm1): 3311, 3188, 3091, 2228, 1899, 1648, 1543. 1H
NMR (100 MHz, DMSO-d6, d, ppm): 2.17 (3H, s, CH3),
4.8 (2H, s, CH2), 5.28 (s, 1H, H-5) 4.11(2H, s, CH2), 2.29
(3H, s, CH3), 7.28 (m, H-Ar), 7.38 (m, 2H, H-Ar), 7.75 (br s,
2H, NH2), 10.99 (s, 1H, NH), 11.55 (s, 1H, NH) ppm,
13C
NMR (100 MHz, DMSO-d6, d, ppm) d: 88.3, 98.5,
114.8, 126.9, 128.8, 129.0, 129.9, 130.5, 135.9, 150.1, 155.4,
155.8, 159.7, 160.9. MS: (M+) m/z, 313, 278, 188, 153, 111,
77, 57, 43.
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tetrahydro-2H-pyrano[2,3-d]pyrimidine-6- carboxylate (4h)
IR (KBr, m cm1): 3340, 3370, 3189, 3080, 2220, 1684, 1567; 1H
NMR (300 MHz, DMSO-d6, d, ppm) 3.2 (s, 3H, CH3), 3.8 (s,
2H, CH2), 4.26 (s, 1H, H-5), 7.17 (s, 2H, NH2), 7.20 (m, 2H,
H-Ar), 7.48 (m, H-Ar), 12.45 (m, s, 1H, NH), 13.66
(m s, 1H, NH) ppm; 13C NMR (100 MHz, DMSO-d6, d,
ppm) d: 35.3, 58.5, 82.8, 119.0, 120.0, 129.9, 132.2, 132.7,
143.0, 157.4, 160.3, 174.0 ppm.
2.2.9. Ethyl7-amino-5-(3-nitrophenyl)-2,4-dioxo-1,3,4,5-
tetrahydro-2H-pyrano[2,3-d]pyrimidine-6- carboxylate (4i)
IR (KBr, m cm1): 3380, 3321, 3182, 2896, 1796, 1640, 1519; 1H
NMR (300 MHz, DMSO-d6, d, ppm): 3.6(3H, s, CH3),
4.1(2H, s, CH2), 4.82 (s, 1H, H-5), 7.26 (s, 2H, NH2), 7.52
(m, 2H, H-Ar), 8.14 (m, 2H, H-Ar), 11.12 (s, 1H, NH),
12.17 (s, 1H, NH) ppm; 13C NMR (100 MHz, DMSO-d6, d,
ppm) d: 35.7, 57.5, 87.5, 119.0, 124.3, 130.7, 146.4, 149.6,
151.9, 152.7, 157.8, 162.6 ppm.
2.2.10. Ethyl 7-amino-5-(4-nitrophenyl)-2,4-dioxo-1,3,4,5-
tetrahydro-2H-pyrano[2,3-d]pyrimidine-6-carboxylate (4j)
IR (KBr, m cm1): 3420, 3367, 3106, 2986, 1978, 1749,1604; 1H
NMR (300 MHz, DMSO-d6, d, ppm): 3.92 (s, 1H, H-5), 7.26
(br s, 2H, NH2), 7.32 (m, 2H, H-Ar), 8.09 (m, 2H, H-Ar),
9.67(s, 1H, NH), 10.15 (s, 1H, NH), 4.12 (s, 2H, CH2), 3.09
(3H, s, CH3) ppm;
13C NMR (100 MHz, DMSO-d6, d, ppm)
d: 37.2, 79.5, 61.7, 121.0, 130.0, 145.4, 148.3, 150.5, 160.3,
162.3, 163.8, 167.2 ppm.
3. Results and discussion
Herein we report a simple synthesis of annulated fused
pyrano[2,3-d]pyrimidinones 4a–j as a domino Knoevenagel–
Michael condensation. The experimental procedure is simple.
Solutions of equimolar amounts of aromatic aldehyde 1, active
methylene compound (ethylcyanoacetate) 2 and barbituric 3 in
ethanol: water mixture at room temperature are mixed thor-
oughly in the presence of a catalytic amount of (10 mol%)
DABCO (Scheme 1). It is imperative to point out here that
the synthesis of pyrano[2,3-d]pyrimidine derivatives involves
three components viz substituted aromatic aldehydes,
barbituric acid and ethylcyanoacetate. We found that someTable 1 Synthesis of some pyrano[2,3-d]pyramidine derivatives.
Product Ar X Color
4a 4-Me-C6H4 CO2C2H5 White solid
4b C6H5 CO2C2H5 Yellow powde
4c 4-MeO-C6H4 CO2C2H5 yellow powder
4d 3,4-MeO-C6H4 CO2C2H5 Yellow powde
4e 3-OH-C6H4 CO2C2H5 Yellow solid
4f 4-OH-C6H4 CO2C2H5 Yellow powde
4g 4-Cl-C6H4 CO2C2H5 White solid
4h 3-Br-C6H6 CO2C2H5 White powder
4i 3-NO2-C6H4 CO2C2H5 White powder
4j 4-NO2-C6H4 CO2C2H5 White powder
x Yields refer to those of pure isolated products characterized by mass
a Heravi et al. [15,16].
b Hamid et al. [14].
c Akbar et al.[1].aromatic aldehydes and barbituric acid are not soluble in pure
water solvent. Therefore time taken for consuming the reac-
tants during the reaction is very high and yield of products is
low under such conditions. Since, addition of a small amount
of ethanol exhibited the complete solubility of key reactants
like barbituric acid which is responsible for the formation of
pyrano[2,3-d]pyrimidines in appropriate time with substantial
yields. Hence, aqueous ethanol 15 ml (1:1 ratio) is employed
as a better solvent compared to pure water in the synthesis
of targeted/model products.
DABCO is bicyclo amine basic in character, so facilitates
proton removal from active methylene compounds thereby
increases reaction rate yields of annulated pyrano[2,3-d]pyri-
midinones. We suggest that DABCO is an effective catalyst
for the formation of the higher reactive iminium group which
is utilized to facilitate Knoevenagel condensation between aryl
aldehydes and active methylene compounds, which proceeds
via intermediate, undergoes dehydration and ﬁnally heterocyc-
lization to produce annulated pyrano[2,3-d]pyramidine deriva-
tives. Table 1 shows the result of a series of representative
aromatic aldehydes with active methylene compounds and bar-
bituric acid to yield pyrano[2,3-d]pyrimidinones 4a–4j as sole
products.DABCO catalyzed synthetic route is easy way to han-
dle, non-corrosive in environmentally benign aqueous media,
cheap, nontoxic and commercially available with advantageous
high product’s selectivity and yields. These formulated pyr-
ano[2,3-d]pyrimidine products as biological agents may become
excellent derivatives for globally alarming drug resistance issues
in clinically used therapeutics. Table 2 shows the effect of differ-
ent concentrations of catalyst for the synthesis of 4b in aqueous
ethanol at room temperature and it was found 10 mol% of
DABCO shows equal or more efﬁcient catalytic activity in
terms of reaction times and yields of the product. In the absence
of the catalyst, the reaction was rather sluggish and resulted in
poor yield (46%) even after 2.5 h time under same reaction con-
ditions, thus conﬁrming DABCO’s role as an efﬁcient catalyst.
Catalyst gets easily removed by aqueous washing due to its sol-
ubility in water; hence no need of further neutralization and
work-up is accomplished by simple ﬁltration and recrystalliza-
tion by ethanol. Prepared derivatives furnish a motivating
model for studying the interaction of pyrano[2,3-d]pyrimidine
with biological target as possible charge modiﬁcation of substi-
tuent and O/N of pharmacophore groups present in skeleton.
The presence of the heteroaryl ring, cyano, amino and differentTime (min) Yield (%)x M.P. (in C)
40 87 296–298 [225]a
r 35 94 206–210 [223]a
40 91 290–293 [297–298]b
r 35 91 303–306 ——
30 93 170–174 [161–163]c
r 40 94 163–167 ———
40 86 295–300 [300]b
40 84 235–237 [222–234]c
35 82 237–240 [265]a
30 83 289–293 [245]a
spectrometry and FTIR, 1H and 13C NMR spectroscopic data.
Table 2 Optimization mol% of DABCO during the synthesis
of 4b in aqueous ethanol.
Entry Mole % of DABCO Time (min) Yield (%)a
1 5 40 81
2 10 40 94
3 15 35 73
4 20 45 70
5 30 30 62
6 40 30 54
7 No catalyst 2.5 h 46
a Isolated yield.
Table 3 Comparative synthesis of 4b using N-type catalyst
(DABCO) versus other catalysts.
Entry Catalyst Mole % Solvent Time
(min)
Yield (%)a
1 Et3N 2–3 drops EtOH: H2O 67 81
2 DBU 10 mol EtOH: H2O 54 78
3 Na2CO3 10 mol EtOH: H2O 95 69
4 NaOH 10 mol EtOH: H2O 127 64
5 K2CO3 10 mol EtOH: H2O 105 57
6 DABCO 10 mol EtOH: H2O 35 94 (Present
work)
a Isolated yields.
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groups on the pyranopyramidine ring makes these more active
for biological evolution. Future ﬂexible pharmacophore site
geometric conformation enables to prepare derivatives for
multi-therapeutic pyrano[2, 3-d]pyrimidine products with high
selectivity.
Further, we have worked on systematic evaluation of differ-
ent catalysts for the model reaction of benzaldehyde, ethyl-
cyanoacetate and barbituric acid using aqueous ethanol
15 ml (1:1 ratio) as solvent (Table 3). We found that yield of
model product 4b (see manuscript Table 1) is 94% using N-
type DABCO catalyst as compared to the other various cata-
lysts such as Et3N, DBU, Na2CO3, NaOH, K2CO3 which is
only 57–81%. These results indicated that time taken for the
synthesis of model product 4b using DABCO is only 35 min
as compared to other catalysts viz Et3N, DBU, Na2CO3,
NaOH, K2CO3 which is more 54–127 min (Table 3). We have
found that due to more addition of Et3N and DBU catalysts
the product formation is very low and the removal of catalysts
by simple washing is very difﬁcult. The synthesis of pyr-
ano[2,3-d]pyrimidines is based on two step mechanism such
as Knoevenagel–Michael addition reaction. The catalysts like
Et3N, DBU, Na2CO3, NaOH, K2CO3 and other catalysts do
not show good results for the synthesis of targeted/model 4b
compound and such catalysts work more efﬁciently only in
simple Knoveangel condition [4,22,25,28,31]. The Michael
addition of barbituric acid on the synthesized arylidene and
the heterocyclization as well as dehydration is not much favor-
able by using such catalysts due to the presence of the hetero-
aryl ring, cyano, amino and different substituent groups on the
pyranopyrimidine ring. Therefore, we used DABCO as an efﬁ-
cient N-type catalyst as compared to the other various organicand inorganic catalysts for one–pot three component synthesis
of pyrano[2,3-d]pyrimidine derivatives.
4. Conclusions
In conclusion we have developed a rapid and an efﬁcient syn-
thetic route for DABCO catalyzed one-pot three component
synthesis of annulated fused pyrano[2,3-d]pyrimidines in aque-
ous ethanol at room temperature and the current synthetic
route has the advantages of operational simplicity, mild reac-
tion conditions and good to high yield of the biological active
products. Our method is simple as no special apparatus,
reagents or chemicals, for work up are required, and the com-
pound formed is ﬁltered and puriﬁed just by simple crystalliza-
tion. This synthesis is also advantageous in terms of atom
economy as well as is devoid of any hazardous chemicals.
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